Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against GeneDx Holdings Corp.
MILWAUKEE, May 5, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims a…
prnewswire.com

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
No analyst coverage available for this stock.
2 signals unavailable — limited data for this stock
Trend
-6.7% vs SMA 50 · +26.6% vs SMA 200
Momentum
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $1.0B $1.0B–$1.0B | — | -$9.98 | — | — | Low1 |
FY2026(current) | $1.1B $1.1B–$1.1B | ▲ +2.4% | $4.16 | — | — | Low1 |
FY2027 | $1.1B $1.1B–$1.1B | ▲ +2.9% | $4.67 | ▲ +12.3% | — | Low1 |
MILWAUKEE, May 5, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims a…

No description available.